A facility-based cross-sectional study of 526 reproductive-age women on antiretroviral therapy in Northwest Ethiopia found that 66.5% were using contraceptives.
SAGE Open Medicine · 4 authors, 3 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
A facility-based cross-sectional study of 526 reproductive-age women on antiretroviral therapy in Northwest Ethiopia found that 66.5% were using contraceptives.
A facility-based cross-sectional study was conducted among 572 women of reproductive age on antiretroviral therapy in Awabel Woreda, Northwest Ethiopia; 526 (91.9%) responded. The prevalence of contraceptive use was 66.5% (95% CI: 63.5, 69.5). Multivariable logistic regression identified urban residence (AOR=1.95, 95% CI: 1.16, 3.72) and disclosure of HIV status to a partner (AOR=2.61, 95% CI: 1.37, 4.95) as positively associated with contraceptive use. Woman's fertility desire (AOR=0.41, 95% CI: 0.24, 0.69) and partner's fertility desire (AOR=0.57, 95% CI: 0.34, 0.97) were negatively associated. Limitations include the absence of qualitative methods to explore cultural norms and lack of a sample size power calculation.